[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364272-105":59,"doc-detail-364272-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identification-and-validation-of-a-metabolic-related-gene-risk-model-predicting-the-prognosis-of-lung-colon-and-breast-cancers","Identification and validation of a metabolic-related gene risk model predicting the prognosis of lung, colon, and breast cancers","","Metabolic reprogramming enables cancer cells to adapt to altered tumor microenvironments, yet shared mechanisms across breast, colorectal, and lung cancers remain insufficiently defined. This study integrates public gene expression data with bioinformatics (MSigDB, WebGestalt, STRING, Cytoscape) to identify hub metabolism-related genes and their interaction networks, then evaluates functional relevance using survival-associated signatures. Key genes are validated via GEPIA2 and qRT-PCR, while machine learning models (KNN, SVR, XGBoost) assess prediction of overall survival, with SVR showing strong accuracy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-and-validation-of-a-metabolic-related-gene-risk-model-predicting-the-prognosis-of-lung-colon-and-breast-cancers/364272/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-and-validation-of-a-metabolic-related-gene-risk-model-predicting-the-prognosis-of-lung-colon-and-breast-cancers/364272.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the study?","Question",{"text":112,"@type":113},"To identify and validate a metabolic-related gene risk model that predicts prognosis across lung, colorectal, and breast cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were key metabolism-related genes (MRGs) identified?",{"text":117,"@type":113},"The study used gene expression data plus bioinformatics tools (MSigDB, WebGestalt, STRING, Cytoscape) to determine hub MRGs and their interaction networks among shared differentially expressed genes.",{"name":119,"@type":110,"acceptedAnswer":120},"What methods were used to validate prognostic genes and their expression?",{"text":121,"@type":113},"Functional relevance was analyzed using GEPIA2, and expression profiles of key MRGs were validated through qRT-PCR in specific cancer cell lines.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},364272,1790334409,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIdentification and validation of a metabolic-related gene risk model predicting the prognosis of lung, colon, and breast cancers  \nJiyauddin Khan1, Chanchal Bareja1,4, Kountay Dwivedi2,4, Ankit Mathur1,3, Naveen Kumar2 & Daman Saluja1,3􀀍  \nMetabolic reprogramming, vital for cancer cells to adapt to the altered microenvironment, remains a topic requiring further investigation for different tumor types. Our study aims to elucidate shared metabolic reprogramming across breast (BRC), colorectal (CRC), and lung (LUC) cancers. Leveraging gene expression data from the Gene Expression Omnibus and various bioinformatics tools like MSigDB, WebGestalt, String, and Cytoscape, we identified key/hub metabolism-related genes (MRGs) and their interactions. The functional characteristics including survival parameters and expression of the key MRGs were analyzed and validated through Gene Expression Profiling Interactive Analysis 2 and qRT-PCR. In addition, we employed machine learning algorithms such as k-nearest neighbours (KNN), support vector regressor (SVR), and extreme gradient boosting (XGBoost) to assess MRGs’effectiveness in predicting overall patient survival. Among 11,384 DEGs analyzed, 540 overlapped across BRC, CRC, and LUC, with 46 MRGs and 20 key/hub MRGs involved in all studied cancer types. Of these, 11 key MRGs were prognostically significant. The qRT-PCR validation of key MRGs in specific cancer cell lines confirmed their expression profiles, with some showing cell-type-specific patterns. SVR exhibited remarkable accuracy in predicting overall survival, emphasizing its clinical utility. Our integrated approach combining bioinformatics analyses and experimental validations underscores the potential of MRGs as biomarkers for metabolic therapies, with machine learning models enhancing predictive capabilities for patient outcomes.  \nKeywords Cancer metabolism, Breast cancer, Colorectal cancer, Lung cancer, Metabolism-related genes, Machine learning, Overall survival, qRT-PCR  \nCancer manifests through a complex interplay of lifestyle choices, external influences, and inherent genetic predispositions, culminating in a myriad of symptoms across individuals, which poses a significant global health challenge1. The International Agency for Research on Cancer (2022) reports that approximately 20 million new cases and nearly 10 million cancer-related deaths occur globally per year2. It further predicts a substantial increase in cancer cases and related deaths over the next two decades. Lung cancer tops the list with (12.4% of total) new cases annually, followed by breast (11.6%), and colorectal cancers (9.6%)2. Currently, the treatment strategies for Breast cancer (BRC), Colorectal cancer (CRC), and Lung Cancer (LUC) primarily centre around surgical resection, chemotherapy, and radiotherapy. To overcome the limitations and challenges inherent in the current therapeutic strategies, ongoing research is delving into novel approaches to enhance treatment outcomes. These efforts encompass targeted therapies, immunotherapy, precision medicine, gene therapy, nanotechnology-based drug delivery systems, and advancements in early detection methods3. More recently, metabolic reprogramming has been established as the hallmark of cancer, enabling cells to survive, proliferate, and maintain essential functions such as biosynthetic capability, redox potential, and energy production. Metabolic remodelling also helps the tumor cells adapt to challenges like hypoxia and nutrient scarcity, contributing to cancer therapy resistance and malignant progression4. During the carcinogenesis process, the metabolic wiring reshuffles, which leads to the acquisition of autonomous and invasive behaviour in transforming cells. Therefore, understanding  \n1Dr B R Ambedkar Center for Biomedical Research, University of Delhi, Delhi 110007, India. 2Department of Computer Science, FacultyofMathe","cbCaibrgCtFz1XIv","https://ap.wps.com/l/cbCaibrgCtFz1XIv","pdf",10622141,"English","# Background and rationale\n## Global cancer burden and current therapies\n## Metabolic reprogramming as a cancer hallmark\n## Need for shared metabolic gene biomarkers\n# Study aim and data integration\n## Gene expression data sources\n## Bioinformatics identification of hub MRGs\n# Functional analysis and validation\n## Survival parameters and expression profiling\n## GEPIA2 and qRT-PCR validation\n# Prognostic modeling\n## Machine learning approaches (KNN, SVR, XGBoost)\n## Prediction performance for overall survival\n# Results and implications\n## Overlap of DEGs and key metabolic genes\n## Potential as biomarkers for metabolic therapies","[{\"question\":\"What is the main goal of the study?\",\"answer\":\"To identify and validate a metabolic-related gene risk model that predicts prognosis across lung, colorectal, and breast cancers.\"},{\"question\":\"How were key metabolism-related genes (MRGs) identified?\",\"answer\":\"The study used gene expression data plus bioinformatics tools (MSigDB, WebGestalt, STRING, Cytoscape) to determine hub MRGs and their interaction networks among shared differentially expressed genes.\"},{\"question\":\"What methods were used to validate prognostic genes and their expression?\",\"answer\":\"Functional relevance was analyzed using GEPIA2, and expression profiles of key MRGs were validated through qRT-PCR in specific cancer cell lines.\"}]","Identification and validation of a metabolic-related gene risk model predicting the prognosis of lung, colon, and breast cancers | PDF",1790156666,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6848be56a368a74a0ffd88944542bd45.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e23582e58dac880540ad7e934cf5bcd.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/71ad53b10d15ede7fcdf19628ed25f76.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3540bb4be6fcd98c551a340b77ae0159.webp",980,1287]